A new research group led by Dr Patrick Pausch started its activity as a part of newly established sui generis operational unit of VU LSC - EMBL Partnership Institute.
Patrick’s group will focus on the development of new CRISPR-Cas and other genome editing tools for biomedical and biotechnology applications. Patrick comes from the UC Berkeley, where he worked for several years at Dr Jennifer Doudna group.
‘I believe the expertise of the new group leader and members of his group will expand our presence in genome editing research areas, contribute towards the development of interdisciplinary research and enhance collaboration between scientists at VU LSC and EMBL. I wish all the best for the new research group. Patrick, welcome to the Life Sciences Center!’ Dr Gintaras Valinčius, Director of VU LSC, said.